The GDNF 1 ligand family, a group of polypeptides structurally related to the transforming growth factor-␤ superfamily, is involved in the control of neuronal survival and differentiation, kidney morphogenesis, and spermatogonial cell fate (1) (2) (3) (4) . Each of the four members of the GDNF family (i.e. GDNF, NTN, ART, and PSP) binds specifically to different members of a small family of glycosylphosphatidylinositol-anchored receptors, the GDNF family ␣-receptors, of which four different members (GFR␣1-4) are currently known (1, 2, 5) . Intracellular signaling is accomplished by the recruitment of a receptor tyrosine kinase, RET, to the GDNF⅐GFR␣ complex. Although all members of the GDNF ligand family utilize RET as a signaling receptor subunit, specificity is achieved by differential binding to individual GFR␣ molecules. GFR␣ receptors can mediate activation of RET when expressed on the surface of the same cell (activation in cis) or when presented in soluble form or immobilized on the cell matrix or neighboring cells (activation in trans) (6, 7) . Upon ligand binding, RET is thought to form dimers and become phosphorylated at specific cytoplasmic tyrosine residues. Tyrosine autophosphorylation is required for the catalytic activity of RET and for downstream signaling. Thus, tyrosine autophosphorylation constitutes the first intracellular event of the RET signaling cascade activated by members of the GDNF ligand family.
Eighteen tyrosine residues, 2 in the juxtamembrane domain, 11 in the kinase domain, and 5 in the carboxyl-terminal tail, are present in the cytoplasmic domain of the long isoform of RET. Tyrosine 905 in the RET kinase domain corresponds to tyrosine 416 in the activation loop of the cytoplasmic tyrosine kinase Src, a conserved residue in many tyrosine kinases known to play a crucial role in kinase activation (8) . Mutation of tyrosine 905 to phenylalanine (Y905F) impairs the kinase activity and abolishes the transforming activity of RET-MEN2A, an oncogenic, constitutively active form of RET identified in patients with multiple endocrine neoplasia type 2A (9) . Tyrosine 905 is also involved in the binding of two adaptor proteins containing SH2 domains, Grb7 and Grb10, presumably involved in downstream signaling events (10 -12 is part of the motif YLXL, a docking site for phospholipase C␥; and mutation of the corresponding residue in the RET/PTC2 oncogene impairs its ability to activate phospholipase C␥ and reduces drastically its oncogenic activity in NIH 3T3 cells (14) . Tyrosine 1062 is part of the motif NKXY, which constitutes a docking site for the phosphotyrosine-binding domain of Shc and FRS2 adaptor proteins. Interaction between phosphorylated Tyr 1062 and either of these two adaptors leads to activation of the Ras/ERK and PI3K/AKT pathways in oncogenic as well as ligand-activated RET (15) (16) (17) (18) (19) (20) . Interestingly, the splicing event that leads to the generation of the short and long isoforms of RET takes place precisely after Tyr 1062 and places this tyrosine residue in a perfect context for binding to SH2 domains in the short (but not the long) RET isoform. Thus, both phosphotyrosine-binding domain-containing and SH2 domain-containing target proteins may bind to this phosphorylated tyrosine in the short RET isoform. Tyrosine 1062 has also been implicated in the binding of Enigma to RET (12) , although this interaction appears to be independent of tyrosine phosphorylation. Recently, a role for this tyrosine residue in the docking and activation of different members of the Dok family of adaptor molecules has also been demonstrated (21) . Mutation of tyrosine 1062 (Y1062F) dramatically impairs the transforming activity of oncogenic RET-MEN2A and RET-MEN2B (22) . Despite its high degree of connectivity to multiple intracellular pathways, the biological function of this residue in the wildtype RET receptor has not been investigated. Finally, tyrosine 1096, located in the 51-residue carboxyl-terminal tail that is specific for the long isoform of RET, is part of the sequence PYXNX, a well known binding site for the Grb2 adaptor protein. Grb2 has been found to interact with the long isoform of RET/PTC2 and wild-type RET via this residue (17, 23) .
In this work, we have investigated the phosphorylation of individual tyrosine residues in the cytoplasmic domain of RET in cell lines, cultured primary neurons, and in vivo. We have studied differences in the kinetics of phosphorylation and dephosphorylation of individual residues and whether different members of the GDNF ligand family may be capable of inducing distinct patterns of tyrosine phosphorylation in RET. For this purpose, we have generated antibodies recognizing the specific phosphorylation of tyrosines 905, 1015, 1062, and 1096 in this receptor. We have introduced several of these phosphotyrosine-specific antibodies into cell lines and primary neurons to investigate the functional roles played by individual tyrosine residues of RET in GDNF-mediated downstream signaling and neuronal survival.
EXPERIMENTAL PROCEDURES
Cell Lines and Reagents-The MG87-␣1/RET and MG87-␣3/RET lines were derived from MG87 fibroblasts by stable transfection of GDNF receptor subunits. MG87-␣1/RET cells express rat GFR␣1 and the long isoform of human RET. MG87-␣3/RET cells express mouse GFR␣3 and the long isoform of human RET. Neuro2A-␣1 cells were generated by stable transfection of the mouse neuroblastoma Neuro2A with rat GFR␣1. MN1 is an immortalized mouse motor neuron cell line (24) . Recombinant rat GDNF was produced in Sf21 insect cells and purified as previously described (25) . Nerve growth factor (NGF) was purchased from Promega, NTN from PeproTech, and GFR␣1-Fc from R&D Systems. Recombinant ART was a generously provided by Bob Gordon (Jannssen Research Foundation, Beerse, Belgium). The Chariot reagent used for protein transduction was from ActiveMotive (Rixensart, Belgium).
Generation of Antibodies-Phosphorylated 15-mer peptides corresponding to four predicted phosphorylation sites in the long isoform of the mouse RET receptor (see Table I ) were synthesized, coupled to keyhole limpet hemocyanin, and used to immunize rabbits by standard procedures. Antisera were evaluated by enzyme-linked immunosorbent assays against phosphorylated and unphosphorylated versions of the peptides. Peptide synthesis, rabbit immunizations, and antibody collection was done by Research Genetics. Antisera showing high titer in enzyme-linked immunosorbent assays were then screened by immunoblotting with protein extracts from control and GDNF-stimulated MG87-␣1/RET cells. Reactive antisera were purified by sequential affinity chromatography steps. Total immunoglobulins were first purified on a protein G column (POROS G, PerSeptive Biosystems) and eluted with 0.1 M glycine (pH 2.7). Antisera to Tyr(P) 905 , Tyr(P) 1015 , and Tyr(P) 1062 showed little or no cross-reactivity against unphosphorylated RET or irrelevant phosphotyrosines and were then affinity-purified over an Affi-Gel 15 affinity column (Bio-Rad) coupled with the corresponding phosphopeptides. Because the anti-Tyr(P) 1096 antisera demonstrated cross-reactivity with unphosphorylated RET as well as other phosphotyrosines, these antibodies were first applied to an Affi-Gel 15 affinity column coupled with the unphosphorylated Tyr 1096 peptide, followed by chromatography on a phosphotyrosine affinity column (Sigma). The eluent from these two steps was then applied to an Affi-Gel affinity column coupled with the Tyr(P) 1096 phosphopeptide. Affinity-purified antibodies were eluted with 0.1 M glycine (pH 2.7), immediately neutralized with 1 M Tris-HCl (pH 9.0), and dialyzed against Tris-buffered saline.
Immunoprecipitation and Immunoblot Analysis-Cell line monolayers in 10-cm plates were changed to serum-free medium 2-4 h prior to stimulation with the indicated factors (10 min unless otherwise indicated). Cells were then lysed in a nonionic ice-cold detergent (lysis buffer: 10 mM Tris-HCl (pH 7.5), 137 mM NaCl, 2 mM EDTA, 10% glycerol, and 1% Nonidet P-40) containing a mixture of protease inhibitors (Roche Molecular Biochemicals) and phosphatase inhibitors (1 mM NaO 4 Va. 20 mM NaF, and 10 mM ␤-glycerophosphate). Cell lysates were cleared by centrifugation at 1500 ϫ g for 10 min and immunoprecipitated by overnight incubation at 4°C with anti-RET antibodies and 40 l of protein G-Sepharose beads (Amersham Biosciences, Inc.). The immunoprecipitates were washed three times with lysis buffer, solubilized in sample buffer, run on SDS-polyacrylamide gels, and blotted onto polyvinylidene difluoride membranes (Amersham Biosciences, Inc.). Blots were first probed with anti-phosphopeptide antibodies, followed by alkaline phosphatase-conjugated anti-IgG, and developed with the enhanced chemi fluorescence Western detection system (Amersham Biosciences, Inc.). All blots were scanned in a Storm 840 fluorimager (Molecular Dynamics, Inc.). For reprobing, blots were stripped for 90 min at room temperature in 0.1 M acetic acid and 0.15 M NaCl. Antibodies against phosphotyrosine (used at 1:1000 dilution) and the long (1:1000) and short (1:500) isoforms of human RET were from Santa Cruz Biotechnology. For peptide competition assays, phosphorylated and unphosphorylated peptides at 10 or 100 nM were preincubated with the antibodies for 30 min at room temperature, and the mixture was then used in immunoblotting.
For developmental analysis of RET phosphorylation, DRG were collected from C57 mice at embryonic day (E) 15, E17, postnatal day (P) 0, P9, P16, and the adult stage in ice-cold Tris-buffered saline containing 1 mM NaO 4 Va. DRG from three mice were pooled for each embryonic time point, whereas DRG from one mouse were enough for postnatal stages. Tissues were lysed in 70 l of 1% lysis buffer, cleared by centrifugation, submitted to SDS-PAGE, and immunoblotted onto polyvinylidene difluoride membranes as described above. Each blot was first probed with an anti-phosphopeptide antibody, stripped, and then reprobed with anti-RET antibodies.
SCG, DRG, and Nodose Ganglion Primary Neuronal Cultures and Survival
Assays-P1 rat SCG were dissociated by incubation for 30 min at 37°C in phosphate-buffered saline containing 0.025% trypsin (Invitrogen) and for an additional 30 min after addition of 5 mg/ml collagenase (Sigma), followed by mechanical trituration. Dissociated cultures from E17 mouse DRG and E9 chick nodose ganglia were prepared by incubation for 10 min at 37°C in phosphate-buffered saline containing 0.025% trypsin, without collagenase and NGF treatments. Neurons were plated in polyornithine/laminin-coated dishes and maintained in neuronal medium (1:1 Dulbecco's modified Eagle's medium/nutrient mixture F-12, Invitrogen), 2 mM glutamine, and 1 mg/ml bovine serum albumin. SCG and nodose ganglion cultures were supplemented with 10 M cytosine ␤-D-arabinofuranoside. SCG neurons were maintained in 20 ng/ml NGF. For biochemical analyses, neurons were maintained for 4 days before a 4-h starvation (i.e. without NGF in the case of SCG) and stimulation with GDNF (100 ng/ml) in the presence or absence of soluble GFR␣1-Fc (100 ng/ml) for the indicated times. The cells were then lysed, and lysates were processed by SDS-PAGE and immunoblotting as described above.
For survival assays, SCG neurons were first maintained for 2 days in neuronal medium supplemented with NGF; washed; and changed to neuronal medium containing either NGF (100 ng/ml) or anti-NGF antibodies (Roche Molecular Biochemicals) together with GDNF (100 ng/ ml) and, where indicated, soluble GFR␣1-Fc (100 ng/ml). DRG neurons were plated directly with the indicated factors without NGF preincubation. Phase-bright, neurite-bearing neurons were counted 24 and 48 h after treatment.
Chariot-mediated Protein Transduction-MN1 cells and chick nodose ganglion neurons were cultured in 24-well plates. Protein transduction using the Chariot reagent was essentially performed according to the manufacturer's instructions. In our hands, the highest efficiency of protein transduction was obtained if performed in serum-free medium with cells still in suspension prior to plating. Because SCG neurons need to be treated for a few days with NGF to develop GDNF responsiveness, antibody transduction was performed in embryonic chick nodose ganglion neurons, which are readily responsive to GDNF immediately after extraction (25) . Two g of antibody was used together with 2 l of Chariot reagent.
After Chariot-mediated transduction, MN1 cells were first allowed to adhere to the plastic plate for 4 h and then stimulated for 5 min with 100 ng/ml GDNF. The cells were lysed as described above, and 10 g of protein lysate was processed by SDS-PAGE and immunoblotting with antibodies against phosphorylated ERK1/2 or phosphorylated AKT (Cell Signaling, New England Biolabs Inc.) at 1:2000 dilution. As a control for loading, the blot was stripped and reprobed with total anti-AKT antibodies (Cell Signaling, New England Biolabs Inc.) used at 1:1000 dilution or anti-tubulin antibodies. Neurite outgrowth assay of MN1 cells was performed as previously described (7). For survival assay, neurons were plated after Chariot-mediated transduction and maintained in 100 ng/ml GDNF for 48 h. Phase-bright neurons were counted in the entire well (between 100 and 400 neurons/well); the results presented are averages of three different wells.
RESULTS

Generation and Characterization of Antibodies to Individual
Phosphotyrosine Sites in RET-To produce polyclonal antibodies directed against specific phosphotyrosine sites in RET, we immunized rabbits with 15-mer synthetic phosphopeptides corresponding to four distinct motifs in the cytoplasmic domain of mouse RET. The phosphotyrosine motifs targeted by this approach included Tyr(P) 905 , Tyr(P) 1015 , Tyr(P) 1062 , and Tyr(P) 1096 . These sequence motifs are highly conserved in RET from other vertebrate species, including rat, chicken, and human (Table I ). The antibodies were purified from rabbit sera by sequential affinity chromatography steps as described under "Experimental Procedures."
In fibroblast cells stably expressing the GFR␣1 co-receptor and the long isoform of human RET (MG87-␣1/RET), antibodies against Tyr(P) 905 , Tyr(P) 1015 , Tyr(P) 1062 , and Tyr(P) 1096 specifically recognized phosphorylated RET in cells treated with GDNF, but not in untreated cells (Fig. 1A) . Similar results were obtained in a mouse motor neuron cell line (MN1) endogenously expressing GDNF receptors (data not shown). Competition experiments indicated that each of the antibodies was specific for the phosphorylated form of its cognate peptide, as only the corresponding phosphopeptide (but not the unphosphorylated peptide or other unrelated phosphopeptides) was able to block the detection of activated RET (Fig. 1A) . The specificity of the antibodies was further tested in fibroblast cells stably expressing mutant forms of human RET carrying specific amino acid replacements of cytoplasmic tyrosines, namely Y1015F, Y1062F, and Y1096F. In each case, detection of ligand-activated RET was abolished by mutation of the corresponding tyrosine residue to phenylalanine (Fig. 1B) , whereas replacement of non-cognate tyrosines had no effect (data not shown). Because mutation of Tyr 905 affects the kinase activity of the receptor, the specificity of the antibodies against Tyr(P) 905 was tested in COS cells transiently overexpressing RET carrying the Y905F mutation. Overexpression in COS cells led to high levels of ligand-independent RET phosphorylation, even in the Y905F mutant, which could be detected with anti-phosphotyrosine antibodies (data not shown) or antiTyr(P) 1015 antibodies (Fig. 1B ), but not with antibodies against Tyr(P) 905 (Fig. 1B) . Because the peptides used for immunization contain sequence motifs that partially overlap with analogous sites in other tyrosine kinase receptors, we tested the ability of our antibodies to detect tyrosine phosphorylation in the neurotrophin-4 receptor TrkB, which, like RET, also contains phosphotyrosine docking sites for Shc, FRS2, and phospholipase C␥. However, none of the four antibodies was able to recognize ligand-activated TrkB (Fig. 1C) , indicating that they are indeed specific for the phosphorylation status of distinct tyrosine residues in RET.
Synchronized Phosphorylation of Individual Tyrosine Residues following Activation of RET in Cis-To study the kinetics of phosphorylation of individual tyrosine residues in RET after ligand stimulation, we used fibroblast cell lines expressing GFR␣1 or GFR␣3 together with the wild-type RET receptor (MG87-␣1/RET and MG87-␣3/RET, respectively) and MN1 cells expressing endogenous GFR␣1, GFR␣2, and RET receptors. GDNF stimulation elicited synchronized phosphorylation of tyrosines 905, 1015, 1062, and 1096 in MG87-␣1/RET cells, corresponding to the pattern of total tyrosine phosphorylation detected by phosphotyrosine antibodies (Fig. 2A) . RET phosphorylation was maximal between 10 and 15 min after ligand stimulation and could still be detected after 120 min ( Fig. 2A) . Dephosphorylation of the 4 tyrosines following maximal activation also proceeded with comparable kinetics in all cases ( Fig. 2A) . Similar results were obtained in MN1 cells, except that tyrosine phosphorylation decayed more rapidly in these cells compared with fibroblast cells (Fig. 2B) . Differences in the kinetics of receptor phosphorylation in different cell types could be due to different levels of receptor expression, as shown for the NGF receptor TrkA (26), or to different complements of protein-tyrosine phosphatases. Phosphorylation of Tyr 905 , Tyr 1015 , and Tyr 1062 was also detected in the short isoform of RET after immunoprecipitation from MN1 cells (data not shown). No differences could be seen between the two RET isoforms regarding activation of individual phosphotyrosine residues.
We also investigated whether different ligands of the GDNF family could induce distinct patterns of phosphorylation of individual tyrosine residues in RET. Stimulation of MG87-␣1/ RET fibroblasts or MN1 cells with NTN resulted in a phospho- 
Grb2
rylation pattern very similar to that observed with GDNF (Fig.  2, C and D) . Also ART, signaling via GFR␣3 in MG87-␣3/RET cells, induced a pattern of tyrosine phosphorylation comparable to those of GDNF and NTN (Fig. 2E) 
FIG. 2. Synchronized phosphorylation of individual tyrosine residues following activation of RET in cis.
Shown are representative immunoblots of RET immunoprecipitates from lysates of MG87-␣1/RET cells (A and C), MN1 cells (B and D), and MG87-␣3/RET cells (E) after stimulation with the indicated ligands (GDNF (A and B), NTN (C and D), and ART (E)) for the indicated periods of time (in minutes)
. Indicated to the left are the antibodies used for immunoblotting in each case. Although small differences could be seen between individual tyrosine sites within a given experiment, these were not consistent from experiment to experiment, indicating that phosphorylation and dephosphorylation were coordinated in the four sites studied. PY and P-Tyr, phosphotyrosine. phosphorylation in parental Neuro2A cells (data not shown). In Neuro2A cells stably transfected with GFR␣1 (Neuro2A-␣1), GDNF induced rapid and transient RET phosphorylation, which returned to basal levels 60 min after treatment (Fig. 3A) . In contrast, stimulation of parental Neuro2A cells with GDNF and a soluble form of GFR␣1 (GFR␣1-Fc) resulted in a delayed but sustained phosphorylation of RET, which persisted for up to 120 min after treatment (Fig. 3B) (Fig. 3B ). In agreement with the pattern of total RET tyrosine phosphorylation, phosphorylation of individual tyrosines was delayed until ϳ10 min and was sustained for up to 120 min (Fig. 3B) . Finally, we compared the patterns of RET tyrosine phosphorylation in MN1 cells expressing RET and GFR␣1 treated with GDNF alone (in cis) versus GDNF plus soluble GFR␣1 (in cis ϩ in trans), a situation more likely to be encountered by neurons that express RET and GFR␣1 in vivo. In this case, treatment with soluble GFR␣1 both potentiated and prolonged phosphorylation of individual RET tyrosines compared with GDNF alone (Fig. 3C) . The phosphorylation patterns of the individual residues were comparable, in support of a synchronized mode of activation after stimulation in trans. Phosphorylation of Tyr 1096 , present in the long RET isoform only, could not be detected in Neuro2A or MN1 cells (data not shown). We think this is due in part to the relatively lower sensitivity of this antibody and also to the fact that, in contrast to the MG87 cell lines used above stably transfected with the RET long isoform, both Neuro2A and MN1 cells express endogenous levels of the short and long isoforms of RET, of which only the latter can be recognized by the anti-Tyr(P) 1096 (Fig. 4A) . Phosphorylation of Tyr 1096 could not be detected in primary neuronal cultures, probably due to the lower sensitivity of this antibody (see above). The individual tyrosines at positions 905 and 1015 also appeared to be phosphorylated in a coordinated way in primary neurons, as was observed in cell lines (Fig. 4B) , with a peak at 10 min and lower levels at 120 min after GDNF stimulation. Similar to MN1 cells, addition of soluble GFR␣1 potentiated and prolonged the phosphorylation of these sites, allowing its detection for up to 24 h of treatment (Fig. 4B) . The increased phosphorylation observed in the presence of soluble GFR␣1 correlated with enhanced survival in culture compared with GDNF alone (Fig. 4C) .
The phosphorylation patterns of individual tyrosine residues in RET were investigated in mouse DRG developing in vivo. Although DRG sensory neurons express both RET and GFR␣ receptors during embryonic development, they have been found to respond in vitro to GDNF only at postnatal stages (27) . We found robust phosphorylation of Tyr 905 , Tyr 1015 , and Tyr 1062 in DRG taken from E15 and E17 mouse embryos (Fig. 4D) . Interestingly, phosphorylation of the 3 residues declined sharply shortly after birth to levels that were barely above detection at postnatal and adult stages (Fig. 4D) . In agreement with a role for RET and GFR␣ receptors in neuronal survival of embryonic mouse DRG neurons, GDNF promoted survival in vitro of dissociated E17 mouse DRG neurons (Fig. 4E) . As in SCG neurons, addition of soluble GFR␣1-Fc potentiated the survival response of embryonic DRG neurons to GDNF (Fig. 4E) .
Phosphorylation of Tyr 1062 Is Required for RET Downstream Signaling and GDNF-mediated Survival of Sensory NeuronsMutations of RET Tyr
1062 affect the ability of GDNF to induce activation of the Ras/ERK and PI3K/AKT pathways in transfected fibroblast cells (17) . The ability of our anti-phosphopeptide antibodies to specifically recognize individual phosphorylated tyrosines in RET prompted us to test the importance of these residues for neuronal survival induced by GDNF. Purified antibodies were introduced into cells in culture using Chariot-mediated protein transduction (see "Experimental Procedures"). Control experiments using tetramethylrhodamine B isothiocyanate-labeled control antibodies demonstrated that nearly 100% of the MN1 cells took up the antibodies only in the presence of the Chariot reagent and without any appreciable toxic effects (data not shown). In MN1 cells, transduction of anti-Tyr(P) 1062 antibodies reduced activation of ERK1 and ERK2 in response to GDNF (Fig. 5A) . No inhibitory effect on ERK phosphorylation could be seen when the Chariot reagent or antibodies were used separately (Fig. 5A) . Because Tyr 1062 is also linked with the PI3K pathway and activation of the AKT kinase (17), we tested phosphorylation of AKT in MN1 cells after transduction with anti-Tyr(P) 1062 antibodies. In the presence of the Chariot reagent, anti-Tyr(P) 1062 antibodies diminished AKT phosphorylation in MN1 cells treated with GDNF (Fig. 5A) , demonstrating that treatment with anti-Tyr(P) 1062 antibodies likely affects all downstream signaling mediated by Tyr 1062 in RET. To evaluate the role of individual RET phosphotyrosine residues in GDNF-mediated biological activities, we used a neurite outgrowth assay in MN1 cells and a survival assay in sensory neurons isolated from the developing chick nodose ganglion, a neuronal subpopulation that is highly responsive to the survival-promoting effects of GDNF (25) (see also "Experimental Procedures"). Cotreatment with GDNF and soluble GFR␣1 produces a robust morphological differentiation of MN1 cells plated in a collagen matrix (7) . Cells that were transduced with anti-Tyr(P) 1062 antibodies showed a greatly attenuated response to the differentiation effects of GDNF ϩ GFR␣1 (Fig.  5B) . Under the same conditions, neither anti-Tyr(P) the GDNF ligand family using different GFR␣ receptors acting in cis or in trans. Our results indicate that phosphorylation of individual tyrosines in RET is developmentally regulated in the DRG in vivo. Finally, using protein transduction into primary neuronal cultures, we demonstrated that phosphorylation of Tyr 1062 is directly involved in GDNF-dependent neuronal survival.
Synchronized Phosphorylation of Individual RET Tyrosine Residues upon Ligand-mediated Activation-Based on crystallographic studies on the insulin ␤-receptor, Hubbard et al. (29) proposed that autophosphorylation of a specific tyrosine(s) in the activation loop is the initial event leading to receptor tyrosine kinase activation. In this model, autophosphorylation of tyrosine 1162 of the insulin ␤-receptor is proposed to induce a conformational change that exposes the ATP-and substratebinding sites for catalysis. Furthermore, phosphorylation of this site was found to be completed before phosphorylation of other tyrosines began (30) , suggesting a stepwise mode of phosphorylation of tyrosine residues during kinase activation. Moreover, in the TrkA receptor, the Shc binding at Tyr 490 remained phosphorylated for a longer time than at tyrosines 674 and 675 in the activation loop (31) . In contrast, our results indicate that, in the RET receptor, tyrosines located within the catalytic and signaling domains are phosphorylated and dephosphorylated in a coordinated way, suggesting that stepwise phosphorylation of activation loop tyrosines is not a general feature of the mechanism of receptor tyrosine kinase activation.
The somewhat unexpected discovery that all four members of the GDNF family signal through a common receptor tyrosine kinase raised the possibility that the different ligands could activate RET in different ways, perhaps through differential phosphorylation of cytoplasmic tyrosines or via differences in strength and duration of autophosphorylation events (32) . In fact, several receptor tyrosine kinases appear to be capable of generating different responses to distinct ligands of otherwise comparable affinity. For example, the neurotrophin receptor TrkB binds both brain-derived neurotrophic factor and neurotrophin-4, and both ligands stimulate activation of MAPKs in cortical neurons (33) . However, only activation by neurotrophin-4 requires an intact Shc-binding site in the cytoplasmic domain of TrkB (33), indicating differences in the signaling mechanisms activated by these two neurotrophins via the TrkB receptor. It has also been shown that the epidermal growth factor receptor can be activated with different kinetics by its two ligands, epidermal growth factor and transforming growth factor-␣ (34) and, more recently, that the four ligands of the ErbB4 receptor (betacellulin and neuregulins 1-3) are able to elicit different patterns of tyrosine phosphorylation in this receptor (35) . Although the limited biochemical evidence available suggests that GDNF and NTN may induce the activation of similar downstream pathways (36) , more recent studies indicate that the two ligands may have different biological effects. For example, both GDNF and NTN are able to promote survival of midbrain dopaminergic neurons after a 6-hydroxydopamine lesion, although only GDNF is capable of stimulating neurite outgrowth from these neurons (37) . In this study, we investigated the phosphorylation patterns of individual tyrosine residues in RET after stimulation with different ligands (e.g. GDNF, NTN, and ART) and in cells expressing a single type of GFR␣ co-receptor (e.g. MG87-␣1/RET and MG87-␣3/ RET cells) or combinations of different GFR␣ receptors (e.g. MN1 cells and peripheral neurons). In none of these cases could we detect significant differences between the kinetics of phosphorylation and dephosphorylation of different tyrosine residues in RET. These observations indicate a robust mechanism of activation for the RET kinase and suggest that the RET receptor is unable to discriminate among different ligands or GFR␣ co-receptors. Differences in the biological activities elicited by different members of the GDNF family could still be explained by the existence of alternative, RET-independent signaling mechanisms, for which some evidence has recently begun to accumulate (38, 39) . ) . B, neurite outgrowth induced by GDNF and GFR␣1 in MN1 cells treated with different Chariot-antibody conjugate combinations. Cells with neurites longer than two-cell diameters were counted in different fields of independent wells. Results are expressed as -fold increase over control (set to 1) and represent the means Ϯ S.E. of three independent experiments performed in triplicate. *, p Ͻ 0.05 versus GDNF ϩ GFR␣1. C, GDNF-mediated survival of E9 chick nodose ganglion neurons treated with different Chariot-antibody conjugate combinations. Guinea pig anti-goat Ig antibodies were used as a control. Results are expressed relative to the survival observed in GDNF alone (set to 100%) and represent the means Ϯ S.E. of three independent experiments performed in triplicate. *, p Ͻ 0.05 versus GDNF. PY, phosphotyrosine.
Increased and Prolonged Phosphorylation of Individual Tyrosine Residues after Activation of RET in Cis plus in Trans-
cating no preferential activation of specific tyrosine sites after stimulation with soluble GFR␣1 receptors. However, RET tyrosine phosphorylation was increased and prolonged in cells stimulated in trans with GDNF and soluble GFR␣1 compared with GDNF alone. In addition, in cells lacking GFR␣1 receptors, RET tyrosine phosphorylation was delayed after stimulation in trans compared with cells expressing endogenous GFR␣1 stimulated in cis (i.e. Fig. 3, A and B) . Thus, although RET is not able to discriminate among different ligands, a quantitative difference in the response of this receptor can be observed when the in cis and in trans stimulation regimes are directly compared. Potentiated and sustained RET tyrosine phosphorylation in SCG neurons after stimulation with GDNF and soluble GFR␣1 correlated with enhanced neuronal survival, comparable to the effects of NGF. Together with recent observations made in developing enteric and sensory neurons (7, 40) , these results demonstrate the generalized potential of exogenous GFR␣ receptors to potentiate the trophic activities of GDNF family ligands.
Robust Phosphorylation of Individual RET Tyrosine Residues during Embryonic Development of DRG Neurons in Vivo-As a first step toward elucidating patterns of RET activation in vivo, we investigated RET phosphorylation in freshly isolated mouse DRG from embryonic and postnatal stages. Our results showed robust phosphorylation of Tyr 905 , Tyr 1015 , and Tyr 1062 at embryonic stages (i.e. E15-17), with a pronounced decrease at early postnatal stages, suggesting that DRG neurons are exposed to high levels of GDNF family ligands during embryonic development. In agreement with this, ART expression has been detected in peripheral nerve roots at this developmental stage (41) . This observation indicates a role for GDNF ligands in the control of neuronal survival and maturation and axonal growth of developing sensory neurons. Intriguingly, a recent developmental study indicated that cultures of dissociated mouse DRG neurons do not respond to the survivalpromoting effects of GDNF family ligands until after birth (27) . However, GDNF-null mutant mice display a 23% loss of DRG neurons already at birth (42) , indicating the requirement of this factor for the survival of DRG neurons during (at least some) embryonic stages in vivo. In agreement with this, we found that GDNF can promote the survival of E17 mouse DRG neurons in vitro and that this activity can be further potentiated by soluble GFR␣1-Fc. Finally, the fact that RET phosphorylation could be seen up to adult stages (only Tyr(P) 905 was analyzed here) indicates that cells in the mouse DRG are continuously exposed to GDNF family ligands in vivo. The functions of these factors in adult sensory neurons are only beginning to be understood and may involve acute regulation of physiological properties such as injury-induced plasticity of sodium channel subunits (43) .
Role of Tyr 1062 in GDNF-mediated Neuronal Differentiation and Survival-Our results using protein transduction of antiphosphopeptide antibodies demonstrate for the first time a role for RET Tyr 1062 in GDNF-mediated neuronal differentiation and survival. The high degree of connectivity of this residue with a number of major intracellular pathways, including the Ras/ERK and PI3K/AKT pathways, predicted an important role for Tyr 1062 in the biological activities of the RET receptor. The fact that this residue constitutes a major (although not the only) route by which RET activates PI3K and AKT, a crucial pathway for GDNF-mediated survival of SCG neurons (17) , is in agreement with its importance for the biological activity of this receptor in sensory neurons. On the other hand, the inability of anti-Tyr(P) 905 and anti-Tyr(P) 1015 antibodies to affect neuronal survival suggests that none of their targets are involved in this activity. Notably, the lack of effect of antibodies against Tyr(P) 905 , a residue involved in the activation of the RET kinase, indicates that, once phosphorylated, this tyrosine does not participate in downstream events required for neuronal survival.
